The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway

L.M. 't Hart, A. Fritsche, G. Nijpels, N. van Leeuwen, L.A. Donnelly, J.M. Dekker, M.J. Alssema, J. Fadista, F. Carlotti, A.P. Gjesing, C.N.A. Palmer, T.W. van Haeften, S.A. Herzberg-Schäfer, A.M.C. Bik-Simonis, J.J. Houwing-Duistermaat, Q. Helmer, J. Deelen, B. Guigas, T. Hansen, F. MachicaoG. Willemsen, R.J. Heine, M.H.H. Kramer, J.J. Holst, E.J.P. de Koning, H.U. Häring, O. Pedersen, L. Groop, E.J.C. de Geus, P.E. Slagboom, D.I. Boomsma, E.M.W. Eekhoff, E.R. Pearson, M. Diamant

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3275-3281
JournalDiabetes
Volume62
Issue number9
DOIs
Publication statusPublished - 2013

Cite this